Medgenics Inc (NYSE MKT LLC:MDGN)

6.80
Data as of Apr 15
 +0.0999 / +1.49%
Today’s Change
3.50
Today|||52-Week Range
9.00
+13.52%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$121.6M

Company Description

Medgenics, Inc. is a medical technology and therapeutics company, which develops protein therapeutics medical therapies. It develops Biopump technology which is used for the treatment of a range of chronic diseases and its product pipeline includes Epodure, Infradure and Hemodure The Company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.

Contact Information

Medgenics, Inc.
Building 700
Wayne Pennsylvania 19087
P:(610) 254-4201
Investor Relations:

Employees

Shareholders

Other institutional6.63%
Mutual fund holders3.08%
Individual stakeholders20.13%

Top Executives

Michael F. ColaPresident, Chief Executive Officer & Director
John Harold LeamanChief Financial Officer & Head-Investor Relations
Nir ShapirVice President-Research & Development
Garry Arthur NeilGlobal Head-Research & Development
Phyllis K. BellinSecretary, Treasurer, CAO & VP-Administration

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.